APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Riboside (NR)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nicotinamide Riboside (NR) Market Analysis and Forecast 2026-2032

27 December 2025219 pages

Choose your research edition.

Industry ResearchNicotinamide Riboside (NR) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Riboside (NR) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Riboside (NR) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Riboside (NR) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Nicotinamide Riboside (NR) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Nicotinamide Riboside (NR)'s global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned ChromaDex as the global sales leader, a title it has maintained for several consecutive years. Notably, ChromaDex's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Nicotinamide Riboside (NR) market include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Nicotinamide Riboside (NR) production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Nicotinamide Riboside (NR) by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Nicotinamide Riboside (NR), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nicotinamide Riboside (NR), also provides the consumption of main regions and countries. Of the upcoming market potential for Nicotinamide Riboside (NR), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Riboside (NR) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nicotinamide Riboside (NR) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nicotinamide Riboside (NR) sales, projected growth trends, production technology, application and end-user industry.

Nicotinamide Riboside (NR) Segment by Company

ChromaDex

Genex Formulas

Bontac

Tiantai Biotechnology

Zhejiang Jiahua

Shandong Tianming Pharmaceutical

Suzhou MyLand Pharm & Nutrition

EnzymeWorks

Longer Livetech

Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) Segment by Type

Purity ≤98%

Purity ＞98%

Nicotinamide Riboside (NR) Segment by Application

Health Supplement

Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Nicotinamide Riboside (NR) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Nicotinamide Riboside (NR) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotinamide Riboside (NR) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nicotinamide Riboside (NR) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity ≤98% Major Manufacturers Table 3. Purity ＞98% Major Manufacturers Table 4. Global Nicotinamide Riboside (NR) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Health Supplement Major Manufacturers Table 6. Pharmaceutical Additives Major Manufacturers Table 7. Nicotinamide Riboside (NR) Industry Trends Table 8. Nicotinamide Riboside (NR) Industry Drivers Table 9. Nicotinamide Riboside (NR) Industry Opportunities and Challenges Table 10. Nicotinamide Riboside (NR) Industry Restraints Table 11. Global Nicotinamide Riboside (NR) Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 12. Global Nicotinamide Riboside (NR) Production by Region (2021-2026) & (Tons) Table 13. Global Nicotinamide Riboside (NR) Production by Region (2027-2032) & (Tons) Table 14. Global Nicotinamide Riboside (NR) Production Market Share by Region (2021-2026) Table 15. Global Nicotinamide Riboside (NR) Production Market Share by Region (2027-2032) Table 16. Global Nicotinamide Riboside (NR) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nicotinamide Riboside (NR) Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Nicotinamide Riboside (NR) Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2021-2026) Table 20. Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2027-2032) Table 21. Global Nicotinamide Riboside (NR) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 22. Global Nicotinamide Riboside (NR) Sales by Region (2021-2026) & (Tons) Table 23. Global Nicotinamide Riboside (NR) Sales by Region (2027-2032) & (Tons) Table 24. Global Nicotinamide Riboside (NR) Sales Market Share by Region (2021-2026) Table 25. Global Nicotinamide Riboside (NR) Sales Market Share by Region (2027-2032) Table 26. Global Nicotinamide Riboside (NR) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nicotinamide Riboside (NR) Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Nicotinamide Riboside (NR) Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Nicotinamide Riboside (NR) Sales Market Share by Manufacturers (2021-2026) Table 30. Global Nicotinamide Riboside (NR) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 31. Global Nicotinamide Riboside (NR) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application Table 34. Global Nicotinamide Riboside (NR) Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Nicotinamide Riboside (NR) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Nicotinamide Riboside (NR) Revenue Market Share by Type (2021-2026) Table 40. Global Nicotinamide Riboside (NR) Revenue Market Share by Type (2027-2032) Table 41. Global Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 42. Global Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 43. Global Nicotinamide Riboside (NR) Sales Market Share by Type (2021-2026) Table 44. Global Nicotinamide Riboside (NR) Sales Market Share by Type (2027-2032) Table 45. Global Nicotinamide Riboside (NR) Price by Type (2021-2026) & (US$/Ton) Table 46. Global Nicotinamide Riboside (NR) Price by Type (2027-2032) & (US$/Ton) Table 47. Global Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Nicotinamide Riboside (NR) Revenue Market Share by Application (2021-2026) Table 50. Global Nicotinamide Riboside (NR) Revenue Market Share by Application (2027-2032) Table 51. Global Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 52. Global Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 53. Global Nicotinamide Riboside (NR) Sales Market Share by Application (2021-2026) Table 54. Global Nicotinamide Riboside (NR) Sales Market Share by Application (2027-2032) Table 55. Global Nicotinamide Riboside (NR) Price by Application (2021-2026) & (US$/Ton) Table 56. Global Nicotinamide Riboside (NR) Price by Application (2027-2032) & (US$/Ton) Table 57. ChromaDex Company Information Table 58. ChromaDex Business Overview Table 59. ChromaDex Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. ChromaDex Nicotinamide Riboside (NR) Product Portfolio Table 61. ChromaDex Recent Development Table 62. Genex Formulas Company Information Table 63. Genex Formulas Business Overview Table 64. Genex Formulas Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Genex Formulas Nicotinamide Riboside (NR) Product Portfolio Table 66. Genex Formulas Recent Development Table 67. Bontac Company Information Table 68. Bontac Business Overview Table 69. Bontac Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Bontac Nicotinamide Riboside (NR) Product Portfolio Table 71. Bontac Recent Development Table 72. Tiantai Biotechnology Company Information Table 73. Tiantai Biotechnology Business Overview Table 74. Tiantai Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 76. Tiantai Biotechnology Recent Development Table 77. Zhejiang Jiahua Company Information Table 78. Zhejiang Jiahua Business Overview Table 79. Zhejiang Jiahua Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio Table 81. Zhejiang Jiahua Recent Development Table 82. Shandong Tianming Pharmaceutical Company Information Table 83. Shandong Tianming Pharmaceutical Business Overview Table 84. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio Table 86. Shandong Tianming Pharmaceutical Recent Development Table 87. Suzhou MyLand Pharm & Nutrition Company Information Table 88. Suzhou MyLand Pharm & Nutrition Business Overview Table 89. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio Table 91. Suzhou MyLand Pharm & Nutrition Recent Development Table 92. EnzymeWorks Company Information Table 93. EnzymeWorks Business Overview Table 94. EnzymeWorks Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio Table 96. EnzymeWorks Recent Development Table 97. Longer Livetech Company Information Table 98. Longer Livetech Business Overview Table 99. Longer Livetech Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Longer Livetech Nicotinamide Riboside (NR) Product Portfolio Table 101. Longer Livetech Recent Development Table 102. Shenzhen Ejion Biotechnology Company Information Table 103. Shenzhen Ejion Biotechnology Business Overview Table 104. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 106. Shenzhen Ejion Biotechnology Recent Development Table 107. North America Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 110. North America Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 111. North America Nicotinamide Riboside (NR) Sales Price by Type (2021-2026) & (US$/Ton) Table 112. North America Nicotinamide Riboside (NR) Sales Price by Type (2027-2032) & (US$/Ton) Table 113. North America Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 116. North America Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 117. North America Nicotinamide Riboside (NR) Sales Price by Application (2021-2026) & (US$/Ton) Table 118. North America Nicotinamide Riboside (NR) Sales Price by Application (2027-2032) & (US$/Ton) Table 119. North America Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 123. North America Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 124. North America Nicotinamide Riboside (NR) Sales by Country (2027-2032) & (Tons) Table 125. North America Nicotinamide Riboside (NR) Sales Price by Country (2021-2026) & (US$/Ton) Table 126. North America Nicotinamide Riboside (NR) Sales Price by Country (2027-2032) & (US$/Ton) Table 127. United States Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 128. Canada Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 129. Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 130. Europe Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 133. Europe Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 134. Europe Nicotinamide Riboside (NR) Sales Price by Type (2021-2026) & (US$/Ton) Table 135. Europe Nicotinamide Riboside (NR) Sales Price by Type (2027-2032) & (US$/Ton) Table 136. Europe Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 139. Europe Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 140. Europe Nicotinamide Riboside (NR) Sales Price by Application (2021-2026) & (US$/Ton) Table 141. Europe Nicotinamide Riboside (NR) Sales Price by Application (2027-2032) & (US$/Ton) Table 142. Europe Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 146. Europe Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 147. Europe Nicotinamide Riboside (NR) Sales by Country (2027-2032) & (Tons) Table 148. Europe Nicotinamide Riboside (NR) Sales Price by Country (2021-2026) & (US$/Ton) Table 149. Europe Nicotinamide Riboside (NR) Sales Price by Country (2027-2032) & (US$/Ton) Table 150. Germany Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 151. France Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 152. U.K. Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 153. Italy Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 155. China Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 156. China Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 157. China Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 158. China Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 159. China Nicotinamide Riboside (NR) Sales Price by Type (2021-2026) & (US$/Ton) Table 160. China Nicotinamide Riboside (NR) Sales Price by Type (2027-2032) & (US$/Ton) Table 161. China Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 162. China Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 163. China Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 164. China Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 165. China Nicotinamide Riboside (NR) Sales Price by Application (2021-2026) & (US$/Ton) Table 166. China Nicotinamide Riboside (NR) Sales Price by Application (2027-2032) & (US$/Ton) Table 167. Asia Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 170. Asia Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 171. Asia Nicotinamide Riboside (NR) Sales Price by Type (2021-2026) & (US$/Ton) Table 172. Asia Nicotinamide Riboside (NR) Sales Price by Type (2027-2032) & (US$/Ton) Table 173. Asia Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 176. Asia Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 177. Asia Nicotinamide Riboside (NR) Sales Price by Application (2021-2026) & (US$/Ton) Table 178. Asia Nicotinamide Riboside (NR) Sales Price by Application (2027-2032) & (US$/Ton) Table 179. Asia Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 183. Asia Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 184. Asia Nicotinamide Riboside (NR) Sales by Country (2027-2032) & (Tons) Table 185. Asia Nicotinamide Riboside (NR) Sales Price by Country (2021-2026) & (US$/Ton) Table 186. Asia Nicotinamide Riboside (NR) Sales Price by Country (2027-2032) & (US$/Ton) Table 187. Japan Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 188. South Korea Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 189. India Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 190. Australia Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 191. China Taiwan Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Nicotinamide Riboside (NR) Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Nicotinamide Riboside (NR) Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 196. SAMEA Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 197. SAMEA Nicotinamide Riboside (NR) Sales Price by Type (2021-2026) & (US$/Ton) Table 198. SAMEA Nicotinamide Riboside (NR) Sales Price by Type (2027-2032) & (US$/Ton) Table 199. SAMEA Nicotinamide Riboside (NR) Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Nicotinamide Riboside (NR) Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 202. SAMEA Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 203. SAMEA Nicotinamide Riboside (NR) Sales Price by Application (2021-2026) & (US$/Ton) Table 204. SAMEA Nicotinamide Riboside (NR) Sales Price by Application (2027-2032) & (US$/Ton) Table 205. SAMEA Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 209. SAMEA Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 210. SAMEA Nicotinamide Riboside (NR) Sales by Country (2027-2032) & (Tons) Table 211. SAMEA Nicotinamide Riboside (NR) Sales Price by Country (2021-2026) & (US$/Ton) Table 212. SAMEA Nicotinamide Riboside (NR) Sales Price by Country (2027-2032) & (US$/Ton) Table 213. Brazil Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 214. Argentina Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 215. Chile Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 216. Colombia Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 217. Peru Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 219. Israel Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 220. UAE Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 221. Turkey Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 222. Iran Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 223. Egypt Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Nicotinamide Riboside (NR) Distributors List Table 227. Nicotinamide Riboside (NR) Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Nicotinamide Riboside (NR) Product Image Figure 2. Global Nicotinamide Riboside (NR) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside (NR) Market Size Share 2021 VS 2025 VS 2032 Figure . Purity ≤98% Image Figure 1. Purity ＞98% Image Figure 2. Global Nicotinamide Riboside (NR) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside (NR) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Health Supplement Image Figure 5. Pharmaceutical Additives Image Figure 6. Global Nicotinamide Riboside (NR) Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 7. Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 8. Global Nicotinamide Riboside (NR) Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Nicotinamide Riboside (NR) Production Market Share by Region (2021-2032) Figure 10. North America Nicotinamide Riboside (NR) Production Growth Rate (2021-2032) & (Tons) Figure 11. Europe Nicotinamide Riboside (NR) Production Growth Rate (2021-2032) & (Tons) Figure 12. China Nicotinamide Riboside (NR) Production Growth Rate (2021-2032) & (Tons) Figure 13. Japan Nicotinamide Riboside (NR) Production Growth Rate (2021-2032) & (Tons) Figure 14. Global Nicotinamide Riboside (NR) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nicotinamide Riboside (NR) Revenue (2021-2032) & (US$ Million) Figure 16. Global Nicotinamide Riboside (NR) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Nicotinamide Riboside (NR) Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2021-2032) Figure 19. Global Nicotinamide Riboside (NR) Sales (2021-2032) & (Tons) Figure 20. Global Nicotinamide Riboside (NR) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 21. Global Nicotinamide Riboside (NR) Sales Market Share by Region (2021-2032) Figure 22. North America Nicotinamide Riboside (NR) Sales YoY (2021-2032) & (Tons) Figure 23. Europe Nicotinamide Riboside (NR) Sales YoY (2021-2032) & (Tons) Figure 24. China Nicotinamide Riboside (NR) Sales YoY (2021-2032) & (Tons) Figure 25. Asia (Excluding China) Nicotinamide Riboside (NR) Sales YoY (2021-2032) & (Tons) Figure 26. South America, Middle East and Africa Nicotinamide Riboside (NR) Sales YoY (2021-2032) & (Tons) Figure 27. Global Nicotinamide Riboside (NR) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Nicotinamide Riboside (NR) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Nicotinamide Riboside (NR) Revenue Market Share by Type (2021-2032) Figure 31. Global Nicotinamide Riboside (NR) Sales Market Share by Type (2021-2032) Figure 32. Global Nicotinamide Riboside (NR) Revenue Market Share by Application (2021-2032) Figure 33. Global Nicotinamide Riboside (NR) Sales Market Share by Application (2021-2032) Figure 34. North America Nicotinamide Riboside (NR) Revenue Share by Type (2021-2032) Figure 35. North America Nicotinamide Riboside (NR) Sales Share by Type (2021-2032) Figure 36. North America Nicotinamide Riboside (NR) Revenue Share by Application (2021-2032) Figure 37. North America Nicotinamide Riboside (NR) Sales Share by Application (2021-2032) Figure 38. North America Nicotinamide Riboside (NR) Revenue Share by Country (2021-2032) Figure 39. North America Nicotinamide Riboside (NR) Sales Share by Country (2021-2032) Figure 40. Europe Nicotinamide Riboside (NR) Revenue Share by Type (2021-2032) Figure 41. Europe Nicotinamide Riboside (NR) Sales Share by Type (2021-2032) Figure 42. Europe Nicotinamide Riboside (NR) Revenue Share by Application (2021-2032) Figure 43. Europe Nicotinamide Riboside (NR) Sales Share by Application (2021-2032) Figure 44. Europe Nicotinamide Riboside (NR) Revenue Share by Country (2021-2032) Figure 45. Europe Nicotinamide Riboside (NR) Sales Share by Country (2021-2032) Figure 46. China Nicotinamide Riboside (NR) Revenue Share by Type (2021-2032) Figure 47. China Nicotinamide Riboside (NR) Sales Share by Type (2021-2032) Figure 48. China Nicotinamide Riboside (NR) Revenue Share by Application (2021-2032) Figure 49. China Nicotinamide Riboside (NR) Sales Share by Application (2021-2032) Figure 50. Asia Nicotinamide Riboside (NR) Revenue Share by Type (2021-2032) Figure 51. Asia Nicotinamide Riboside (NR) Sales Share by Type (2021-2032) Figure 52. Asia Nicotinamide Riboside (NR) Revenue Share by Application (2021-2032) Figure 53. Asia Nicotinamide Riboside (NR) Sales Share by Application (2021-2032) Figure 54. Asia Nicotinamide Riboside (NR) Revenue Share by Country (2021-2032) Figure 55. Asia Nicotinamide Riboside (NR) Sales Share by Country (2021-2032) Figure 56. SAMEA Nicotinamide Riboside (NR) Revenue Share by Type (2021-2032) Figure 57. SAMEA Nicotinamide Riboside (NR) Sales Share by Type (2021-2032) Figure 58. SAMEA Nicotinamide Riboside (NR) Revenue Share by Application (2021-2032) Figure 59. SAMEA Nicotinamide Riboside (NR) Sales Share by Application (2021-2032) Figure 60. SAMEA Nicotinamide Riboside (NR) Revenue Share by Country (2021-2032) Figure 61. SAMEA Nicotinamide Riboside (NR) Sales Share by Country (2021-2032) Figure 62. Nicotinamide Riboside (NR) Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Nicotinamide Riboside (NR) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≤98%
  • Purity ＞98%
Applications
  • Health Supplement
  • Pharmaceutical Additives
Companies covered
  • ChromaDex
  • Genex Formulas
  • Bontac
  • Tiantai Biotechnology
  • Zhejiang Jiahua
  • Shandong Tianming Pharmaceutical
  • Suzhou MyLand Pharm & Nutrition
  • EnzymeWorks
  • Longer Livetech
  • Shenzhen Ejion Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nicotinamide Riboside (NR) Market by Type
  3. 1.2.1 Global Nicotinamide Riboside (NR) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity ≤98%
  5. 1.2.3 Purity ＞98%
  6. 1.3 Nicotinamide Riboside (NR) Market by Application
  7. 1.3.1 Global Nicotinamide Riboside (NR) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Health Supplement
  9. 1.3.3 Pharmaceutical Additives
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Nicotinamide Riboside (NR) Market Dynamics
  1. 2.1 Nicotinamide Riboside (NR) Industry Trends
  2. 2.2 Nicotinamide Riboside (NR) Industry Drivers
  3. 2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Global Nicotinamide Riboside (NR) Production Overview
  1. 3.1 Global Nicotinamide Riboside (NR) Production Capacity (2021-2032)
  2. 3.2 Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Nicotinamide Riboside (NR) Production by Region
  4. 3.3.1 Global Nicotinamide Riboside (NR) Production by Region (2021-2026)
  5. 3.3.2 Global Nicotinamide Riboside (NR) Production by Region (2027-2032)
  6. 3.3.3 Global Nicotinamide Riboside (NR) Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Nicotinamide Riboside (NR) Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Nicotinamide Riboside (NR) Revenue by Region
  3. 4.2.1 Global Nicotinamide Riboside (NR) Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Nicotinamide Riboside (NR) Revenue by Region (2021-2026)
  5. 4.2.3 Global Nicotinamide Riboside (NR) Revenue by Region (2027-2032)
  6. 4.2.4 Global Nicotinamide Riboside (NR) Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Nicotinamide Riboside (NR) Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Nicotinamide Riboside (NR) Sales by Region
  9. 4.4.1 Global Nicotinamide Riboside (NR) Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Nicotinamide Riboside (NR) Sales by Region (2021-2026)
  11. 4.4.3 Global Nicotinamide Riboside (NR) Sales by Region (2027-2032)
  12. 4.4.4 Global Nicotinamide Riboside (NR) Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Nicotinamide Riboside (NR) Revenue by Manufacturers
  2. 5.1.1 Global Nicotinamide Riboside (NR) Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Nicotinamide Riboside (NR) Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Nicotinamide Riboside (NR) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Nicotinamide Riboside (NR) Sales by Manufacturers
  6. 5.2.1 Global Nicotinamide Riboside (NR) Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Nicotinamide Riboside (NR) Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Nicotinamide Riboside (NR) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Nicotinamide Riboside (NR) Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Nicotinamide Riboside (NR) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application
  13. 5.7 Global Nicotinamide Riboside (NR) Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
  16. 5.8.2 2025 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
6 Nicotinamide Riboside (NR) Market by Type
  1. 6.1 Global Nicotinamide Riboside (NR) Revenue by Type
  2. 6.1.1 Global Nicotinamide Riboside (NR) Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Nicotinamide Riboside (NR) Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Nicotinamide Riboside (NR) Sales by Type
  5. 6.2.1 Global Nicotinamide Riboside (NR) Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Nicotinamide Riboside (NR) Sales Market Share by Type (2021-2032)
  7. 6.3 Global Nicotinamide Riboside (NR) Price by Type
7 Nicotinamide Riboside (NR) Market by Application
  1. 7.1 Global Nicotinamide Riboside (NR) Revenue by Application
  2. 7.1.1 Global Nicotinamide Riboside (NR) Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Nicotinamide Riboside (NR) Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Nicotinamide Riboside (NR) Sales by Application
  5. 7.2.1 Global Nicotinamide Riboside (NR) Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Nicotinamide Riboside (NR) Sales Market Share by Application (2021-2032)
  7. 7.3 Global Nicotinamide Riboside (NR) Price by Application
8 Company Profiles
  1. 8.1 ChromaDex
  2. 8.1.1 ChromaDex Company Information
  3. 8.1.2 ChromaDex Business Overview
  4. 8.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
  6. 8.1.5 ChromaDex Recent Developments
  7. 8.2 Genex Formulas
  8. 8.2.1 Genex Formulas Company Information
  9. 8.2.2 Genex Formulas Business Overview
  10. 8.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
  12. 8.2.5 Genex Formulas Recent Developments
  13. 8.3 Bontac
  14. 8.3.1 Bontac Company Information
  15. 8.3.2 Bontac Business Overview
  16. 8.3.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
  18. 8.3.5 Bontac Recent Developments
  19. 8.4 Tiantai Biotechnology
  20. 8.4.1 Tiantai Biotechnology Company Information
  21. 8.4.2 Tiantai Biotechnology Business Overview
  22. 8.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  24. 8.4.5 Tiantai Biotechnology Recent Developments
  25. 8.5 Zhejiang Jiahua
  26. 8.5.1 Zhejiang Jiahua Company Information
  27. 8.5.2 Zhejiang Jiahua Business Overview
  28. 8.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
  30. 8.5.5 Zhejiang Jiahua Recent Developments
  31. 8.6 Shandong Tianming Pharmaceutical
  32. 8.6.1 Shandong Tianming Pharmaceutical Company Information
  33. 8.6.2 Shandong Tianming Pharmaceutical Business Overview
  34. 8.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
  36. 8.6.5 Shandong Tianming Pharmaceutical Recent Developments
  37. 8.7 Suzhou MyLand Pharm & Nutrition
  38. 8.7.1 Suzhou MyLand Pharm & Nutrition Company Information
  39. 8.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
  40. 8.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
  42. 8.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
  43. 8.8 EnzymeWorks
  44. 8.8.1 EnzymeWorks Company Information
  45. 8.8.2 EnzymeWorks Business Overview
  46. 8.8.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
  48. 8.8.5 EnzymeWorks Recent Developments
  49. 8.9 Longer Livetech
  50. 8.9.1 Longer Livetech Company Information
  51. 8.9.2 Longer Livetech Business Overview
  52. 8.9.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
  54. 8.9.5 Longer Livetech Recent Developments
  55. 8.10 Shenzhen Ejion Biotechnology
  56. 8.10.1 Shenzhen Ejion Biotechnology Company Information
  57. 8.10.2 Shenzhen Ejion Biotechnology Business Overview
  58. 8.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  60. 8.10.5 Shenzhen Ejion Biotechnology Recent Developments
9 North America
  1. 9.1 North America Nicotinamide Riboside (NR) Market Size by Type
  2. 9.1.1 North America Nicotinamide Riboside (NR) Revenue by Type (2021-2032)
  3. 9.1.2 North America Nicotinamide Riboside (NR) Sales by Type (2021-2032)
  4. 9.1.3 North America Nicotinamide Riboside (NR) Price by Type (2021-2032)
  5. 9.2 North America Nicotinamide Riboside (NR) Market Size by Application
  6. 9.2.1 North America Nicotinamide Riboside (NR) Revenue by Application (2021-2032)
  7. 9.2.2 North America Nicotinamide Riboside (NR) Sales by Application (2021-2032)
  8. 9.2.3 North America Nicotinamide Riboside (NR) Price by Application (2021-2032)
  9. 9.3 North America Nicotinamide Riboside (NR) Market Size by Country
  10. 9.3.1 North America Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Nicotinamide Riboside (NR) Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
10 Europe
  1. 10.1 Europe Nicotinamide Riboside (NR) Market Size by Type
  2. 10.1.1 Europe Nicotinamide Riboside (NR) Revenue by Type (2021-2032)
  3. 10.1.2 Europe Nicotinamide Riboside (NR) Sales by Type (2021-2032)
  4. 10.1.3 Europe Nicotinamide Riboside (NR) Price by Type (2021-2032)
  5. 10.2 Europe Nicotinamide Riboside (NR) Market Size by Application
  6. 10.2.1 Europe Nicotinamide Riboside (NR) Revenue by Application (2021-2032)
  7. 10.2.2 Europe Nicotinamide Riboside (NR) Sales by Application (2021-2032)
  8. 10.2.3 Europe Nicotinamide Riboside (NR) Price by Application (2021-2032)
  9. 10.3 Europe Nicotinamide Riboside (NR) Market Size by Country
  10. 10.3.1 Europe Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Nicotinamide Riboside (NR) Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Netherlands
11 China
  1. 11.1 China Nicotinamide Riboside (NR) Market Size by Type
  2. 11.1.1 China Nicotinamide Riboside (NR) Revenue by Type (2021-2032)
  3. 11.1.2 China Nicotinamide Riboside (NR) Sales by Type (2021-2032)
  4. 11.1.3 China Nicotinamide Riboside (NR) Price by Type (2021-2032)
  5. 11.2 China Nicotinamide Riboside (NR) Market Size by Application
  6. 11.2.1 China Nicotinamide Riboside (NR) Revenue by Application (2021-2032)
  7. 11.2.2 China Nicotinamide Riboside (NR) Sales by Application (2021-2032)
  8. 11.2.3 China Nicotinamide Riboside (NR) Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Nicotinamide Riboside (NR) Market Size by Type
  2. 12.1.1 Asia Nicotinamide Riboside (NR) Revenue by Type (2021-2032)
  3. 12.1.2 Asia Nicotinamide Riboside (NR) Sales by Type (2021-2032)
  4. 12.1.3 Asia Nicotinamide Riboside (NR) Price by Type (2021-2032)
  5. 12.2 Asia Nicotinamide Riboside (NR) Market Size by Application
  6. 12.2.1 Asia Nicotinamide Riboside (NR) Revenue by Application (2021-2032)
  7. 12.2.2 Asia Nicotinamide Riboside (NR) Sales by Application (2021-2032)
  8. 12.2.3 Asia Nicotinamide Riboside (NR) Price by Application (2021-2032)
  9. 12.3 Asia Nicotinamide Riboside (NR) Market Size by Country
  10. 12.3.1 Asia Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Nicotinamide Riboside (NR) Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Nicotinamide Riboside (NR) Market Size by Type
  2. 13.1.1 SAMEA Nicotinamide Riboside (NR) Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Nicotinamide Riboside (NR) Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Nicotinamide Riboside (NR) Price by Type (2021-2032)
  5. 13.2 SAMEA Nicotinamide Riboside (NR) Market Size by Application
  6. 13.2.1 SAMEA Nicotinamide Riboside (NR) Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Nicotinamide Riboside (NR) Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Nicotinamide Riboside (NR) Price by Application (2021-2032)
  9. 13.3 SAMEA Nicotinamide Riboside (NR) Market Size by Country
  10. 13.3.1 SAMEA Nicotinamide Riboside (NR) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Nicotinamide Riboside (NR) Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Nicotinamide Riboside (NR) Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Nicotinamide Riboside (NR) Value Chain Analysis
  2. 14.1.1 Nicotinamide Riboside (NR) Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Nicotinamide Riboside (NR) Production Mode & Process
  6. 14.2 Nicotinamide Riboside (NR) Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Nicotinamide Riboside (NR) Distributors
  9. 14.2.3 Nicotinamide Riboside (NR) Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst